Back to Search
Start Over
Albireo Pharma reports Q3 EPS (1.73), consensus ($1.56)
- Source :
- The Fly. November 6, 2019
- Publication Year :
- 2019
-
Abstract
- Reports Q3 revenue $1.4M, consensus $960,000. 'Randomization of patients in our Phase 3 trial of odevixibat in PFIC is nearing completion, and we remain on track to report topline results [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.604934199